Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average Target Price from Analysts

Celcuity Inc. (NASDAQ:CELC) has been assigned an average recommendation of “Buy” from the seven ratings firms that are covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $29.17.

Several brokerages have recently issued reports on CELC. Needham & Company LLC reaffirmed a “buy” rating and issued a $23.00 price target on shares of Celcuity in a research report on Friday, November 15th. Stifel Nicolaus raised their price target on Celcuity from $39.00 to $42.00 and gave the company a “buy” rating in a research report on Monday, October 7th. Finally, HC Wainwright reissued a “buy” rating and set a $27.00 target price on shares of Celcuity in a research report on Friday, November 15th.

Institutional Investors Weigh In On Celcuity

Institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets boosted its holdings in Celcuity by 2,083.4% during the third quarter. BNP Paribas Financial Markets now owns 45,110 shares of the company’s stock valued at $673,000 after purchasing an additional 43,044 shares in the last quarter. Samlyn Capital LLC grew its holdings in Celcuity by 92.4% during the 2nd quarter. Samlyn Capital LLC now owns 1,326,953 shares of the company’s stock worth $21,735,000 after acquiring an additional 637,190 shares during the period. Driehaus Capital Management LLC grew its holdings in Celcuity by 62.3% during the 2nd quarter. Driehaus Capital Management LLC now owns 204,592 shares of the company’s stock worth $3,351,000 after acquiring an additional 78,525 shares during the period. Geode Capital Management LLC grew its holdings in Celcuity by 27.6% during the 3rd quarter. Geode Capital Management LLC now owns 630,369 shares of the company’s stock worth $9,401,000 after acquiring an additional 136,518 shares during the period. Finally, Blue Owl Capital Holdings LP acquired a new stake in Celcuity during the 2nd quarter worth $1,065,000. 63.33% of the stock is owned by institutional investors and hedge funds.

Celcuity Trading Down 2.8 %

Shares of NASDAQ:CELC opened at $10.93 on Tuesday. The company has a market cap of $405.83 million, a P/E ratio of -4.19 and a beta of 0.74. The stock’s 50-day moving average is $12.78 and its 200-day moving average is $14.97. Celcuity has a 52-week low of $10.35 and a 52-week high of $22.19. The company has a debt-to-equity ratio of 0.65, a quick ratio of 10.36 and a current ratio of 10.35.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.